WHO Guideline Development Group advises against use of remdesivir for COVID-19
The antiviral drug remdesivir is not suggested for patients admitted to hospital with COVID-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the need for ventilation, ...